[MARS (Molecular Absorbent Recirculating System) as hepatic extracorporeal care in serious acute liver failure of...

Area of Science:

• Hepatology
• Critical Care Medicine
• Biomedical Engineering

Background:

• Acute liver failure, particularly alcoholic hepatitis, presents a significant global health challenge with high mortality rates, often necessitating intensive care unit (ICU) admission.
• Severe alcoholic hepatitis is clinically defined by a Maddrey score exceeding 32 and/or the presence of spontaneous encephalopathy.
• Standard treatments include corticosteroids, nutritional support, alcohol abstinence, and potentially anti-TNF therapy.

Observation:

• The study introduces the Molecular Adsorbent recirculating System (MARS), an extracorporeal liver support system with detoxification capabilities.
• MARS is utilized as a temporary measure to stabilize patients awaiting liver transplantation or native liver recovery.
• The system aims to bridge the gap until definitive treatment or natural recovery occurs.

Findings:

• MARS, when used adjunctively with established therapies, demonstrated 'spectacular' and durable positive outcomes in patients with severe alcoholic hepatitis.
• The extracorporeal detoxification provided by MARS contributed to maintaining patient stability.
• Sustained improvements were observed over time, suggesting the long-term efficacy of MARS in this critical patient group.

Implications:

• MARS offers a valuable supportive strategy in managing severe alcoholic hepatitis, potentially improving patient outcomes and survival.
• This extracorporeal liver assistance may reduce the burden on liver transplant waiting lists by facilitating native liver recovery.
• Further research into MARS's long-term impact and optimal integration into treatment protocols for acute liver failure is warranted.